AXT, Inc. has lost another fifth of its value this week, deepening a collapse that began when insiders cashed out $21 million near the top — and the market is now asking a sharper question: with shorts rebuilding and earnings just three weeks away, where does the stock find a floor?
The short interest picture has grown more pointed since last week's note. Bears control 19.1% of the free float — up roughly 10% in a single session on July 7 and now back above the levels seen before a brief mid-June squeeze in positioning. That reads as active rebuilding, not inertia. Yet the borrow market tells a notably different story. Availability is wide at 384%, meaning there are nearly four shares available to borrow for every one already shorted — far from a constrained pool. Cost to borrow is minimal at 0.42%, having drifted lower over the past month even as the share price fell. There is no mechanical squeeze pressure here. Bears are adding risk in a liquid, cheap-to-borrow environment, which suggests the positioning is conviction-driven rather than momentum-forced.
Options positioning has flipped sharply in the opposite direction. The put/call ratio has dropped to 0.74, more than two standard deviations below its 20-day average of 0.96 — the most call-heavy reading in weeks. Six weeks ago the PCR sat above 1.19 during the stock's run-up; it has now reversed hard as the stock retraces. That divergence between a rebuilding short base and a call-leaning options market is the week's central tension. Either options traders are bottom-fishing after a 35% one-month decline, or short sellers are the ones reading the setup correctly ahead of the July 30 Q2 print.
The Street has gone quiet since the post-earnings enthusiasm of late April and early May, when Wedbush raised its target to $93 and maintained an Outperform. At current prices of $58.15 the stock trades at a 38% discount to that target, but the most recent analyst data is now more than five weeks old and no fresh coverage has followed the decline. That silence matters. The bull case — strong Asia Pacific demand, potential margin upside, a landmark supply deal with Coherent — remains structurally intact per the Wedbush thesis. The bear case has grown louder in the price: China revenue concentration, raw material sales weakness, and a valuation that still looks stretched on some metrics. The PE multiple has compressed sharply, down more than 157 points over 30 days to 135x, and EV/EBITDA has fallen 20 points in the same window to 100x — still elevated for a company whose EPS surprise factor ranks only in the 28th percentile.
The institutional flow adds texture. Jane Street holds 7.5% of shares and added 2.3 million shares as recently as late April. Marex added almost its entire 4 million-share position around May 1. Both filings predate the June peak — their current posture is unknown. What is known is that Morris Young, the Founder and CEO, trimmed 126,995 shares net in the most recent reported period, continuing the broader insider selling trend documented in the previous note. The insider selling was at $87–$115; the stock closed Tuesday at $58.15.
The July 30 earnings date is the immediate focal point — Q1 produced a one-day move of +35% and a five-day move of +53%, so the market has learned to price this name for large swings. Whether the call-heavy options market is anticipating a repeat, or shorts rebuilding at 19% of the float are pricing in disappointment, is what the next three weeks will clarify.
See the live data behind this article on ORTEX.
Open AXTI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
